WallStreetZenWallStreetZen
Analyst Ranking
Bottom 13%
#4043 out of 4591 analysts
Average Return
-0.94%
Win Rate
48%52 out of 109
Risk vs Reward
Poor
Good

Tazeen Ahmad's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Immunomedics IncIMMU
+339.08%$20.01$87.86
2019-12-20 -
2020-10-22
Strong Buy
Argenx SeARGX
+133.81%$157.46$368.16
2020-02-10 -
2021-02-10
Strong Buy
Avexis IncAVXS
+127.40%$95.79$217.83
2017-11-10 -
2018-05-15
Strong Buy
Ascendis Pharma AASND
+109.30%$71.43$149.50
2023-04-04 -
2024-04-03
Strong Buy
Acadia Pharmaceuticals IncACAD
+100.00%$20.24$40.48
2018-10-10 -
2019-10-10
Strong Buy

Tazeen Ahmad's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Acadia Pharmaceuticals IncACAD
9Hold$22.00+41.57%Maintains
15 days ago
Amicus Therapeutics IncFOLD
2Strong Buy$13.00+37.28%Maintains
15 days ago
Rhythm Pharmaceuticals IncRYTM
6Hold$42.00+12.39%Downgrades
17 days ago
Sutro Biopharma IncSTRO
1Strong Buy$12.00+194.12%Initiates Coverage On
17 days ago
Sage Therapeutics IncSAGE
12Sell$14.00+23.67%Downgrades
a month ago
Inozyme Pharma IncINZY
2Strong Buy$14.00+207.02%Maintains
a month ago
Annexon IncANNX
4Strong Buy$10.00+112.77%Maintains
2 months ago
Fate Therapeutics IncFATE
2Sell$6.00+74.93%Maintains
2 months ago
Incyte CorpINCY
2Hold$67.00+16.62%Maintains
2 months ago
Ocular Therapeutix IncOCUL
1Strong Buy$15.00+158.62%Initiates Coverage On
4 months ago
Prothena Corp Public Ltd CoPRTA
3Hold$38.00+89.05%Downgrades
4 months ago
Cyteir Therapeutics IncCYTT
2Sell$3.00-0.66%Downgrades
5 months ago
Achilles Therapeutics PLCACHL
1Sell$0.50-44.20%Downgrades
5 months ago
Pharvaris NvPHVS
3Sell$11.00-43.73%Maintains
6 months ago
Apellis Pharmaceuticals IncAPLS
1Strong Buy$85.00+114.21%Upgrades
6 months ago
Ptc Therapeutics IncPTCT
9Sell$23.00-38.06%Maintains
8 months ago
Cerevel Therapeutics Holdings IncCERE
2Hold$31.00-25.53%Downgrades
10 months ago
Biocryst Pharmaceuticals IncBCRX
2Strong Buy$10.00+57.98%Upgrades
10 months ago
4d Molecular Therapeutics IncFDMT
2Strong Buy$33.00+31.21%Maintains
a year ago
Sarepta Therapeutics IncSRPT
20Strong Buy$176.00N/AMaintains
a year ago
Adc Therapeutics SaADCT
2Sell$2.00N/ADowngrades
a year ago
Ascendis Pharma AASND
5Strong Buy$92.00N/AMaintains
a year ago
Biontech SeBNTX
5Strong Buy$194.00N/AMaintains
a year ago
Galera Therapeutics IncGRTX
2Strong Buy$7.00N/AUpgrades
a year ago
Sqz Biotechnologies CoSQZB
2Sell$2.00N/ADowngrades
a year ago
Prelude Therapeutics IncPRLD
4Sell$6.00N/ADowngrades
2 years ago
Surrozen IncSRZN
3Sell$15.00N/ADowngrades
2 years ago
Praxis Precision Medicines IncPRAX
2Hold$60.00N/ADowngrades
2 years ago
Pepgen IncPEPG
1Strong Buy$16.00N/AInitiates Coverage On
2 years ago
Molecular Templates IncMTEM
2Sell$22.50N/ADowngrades
2 years ago
Pyxis Oncology IncPYXS
1Hold$16.00N/AInitiates Coverage On
3 years ago
Quince Therapeutics IncQNCX
1SellN/AN/ADowngrades
3 years ago
Arvinas IncARVN
1Strong Buy$110.00N/AInitiates Coverage On
3 years ago
Ultragenyx Pharmaceutical IncRARE
3Strong Buy$162.00N/AUpgrades
3 years ago
Akouos IncAKUS
2Hold$20.00N/ADowngrades
3 years ago
Orphazyme AORPHY
1Sell$5.00N/ADowngrades
3 years ago
Argenx SeARGX
2Strong Buy$298.00N/AMaintains
4 years ago
89bio IncETNB
1Strong Buy$43.00N/AUpgrades
4 years ago
Fulcrum Therapeutics IncFULC
2Sell$11.00N/ADowngrades
4 years ago
Clovis Oncology IncCLVSQ
1Sell$6.00N/ADowngrades
4 years ago
Immunomedics IncIMMU
1Strong Buy$26.00N/AInitiates Coverage On
4 years ago
Dbv Technologies SaDBVT
1Strong Buy$30.00N/AMaintains
6 years ago
Tesaro IncTSRO
4Hold$39.00N/AMaintains
6 years ago
Spero Therapeutics IncSPRO
2Sell$9.00N/ADowngrades
6 years ago
Pacira Biosciences IncPCRX
3Hold$48.00N/AMaintains
6 years ago
Adamas Pharmaceuticals IncADMS
2Hold$25.00N/ADowngrades
6 years ago
Gw Pharmaceuticals PLCGWPH
3Strong Buy$200.00N/AMaintains
6 years ago
Ptc IncPTC
3Hold$102.00N/AMaintains
6 years ago
Neurocrine Biosciences IncNBIX
1Strong Buy$102.00N/AMaintains
6 years ago
Seagen IncSGEN
1Hold$68.00N/AMaintains
6 years ago
Avexis IncAVXS
1Strong Buy$112.00N/AMaintains
7 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.